Basic Information
Medlinker, founded in 2014, is a leading chronic disease management platform in China. It is dedicated to providing long-term standardized specialist chronic disease management services for a wide range of chronic disease patients, using technology to help these patients lead high-quality lives. Currently, the Medlinker platform has gathered more than 800,000 real-name authenticated doctors and over 50,000 contracted doctors across China, covering various chronic disease fields such as liver disease, diabetes, HIV, cancer, kidney disease, cardiovascular and cerebrovascular diseases, pediatrics, mental health, respiratory asthma, and more. The platform offers patients treatment recommendations, treatment effectiveness evaluations, electronic prescriptions, medication guidance, psychological counseling, lifestyle interventions, and other effective, affordable, and accessible out-of-hospital chronic disease management services, enabling patients to achieve effective control of their conditions. Medlinker is a mobile platform based on real-name authentication, academic social networking, and free practice for doctors. Doctors can share case studies, engage in academic discussions, clinical exchanges, and surgical consultations. Leveraging medical big data and artificial intelligence technologies, Medlinker promotes the development of innovative medical applications, optimizes the overall efficiency of the medical supply side, and continuously refines its full industry chain centered around smart internet hospital solutions. Its business operations are gradually penetrating upstream and downstream sectors of the broader healthcare industry chain, including medical institutions, pharmaceutical and medical device manufacturers, government agencies, and commercial insurance providers, offering standardized and customized medical solutions.
Chengdu Yiyun Technology Co., Ltd.
Sichuan,China
more than 500 people
June 26, 2014
media@medlinker.com

